EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Impact of Aortic Atherosclerosis on Clinical Outcomes After Transfemoral Transcatheter Aortic Valve Replacement

Yoshinori Shirai, Akihito Tanaka iD, Yoshiyuki Tokuda, Hiroki Kondo, Koji Mizutani, Tomonari Uemura iD, Kenji Furusawa, Masato Mutsuga, Toyoaki Murohara

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70125 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Yoshinori Shirai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Femoral Artery, Aortic Diseases, Atherosclerosis. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Aortic atherothrombotic lesions can cause systemic embolization and adverse outcomes after interventional procedures.

Aims

This study aimed to assess the association between the degree of aortic atherosclerosis and clinical outcomes after transfemoral transcatheter aortic valve replacement (TAVR).

Methods

This single‐center observational study included data from 278 patients who underwent transfemoral TAVR. The degree of aortic atherosclerosis in the ascending aorta, aortic arch, descending aorta, and abdominal aorta according to preoperative enhanced computed tomography was evaluated, and extensive intimal thickening ≥ 4 mm or mobile‐looking, ulcerated or protruding atheroma were considered to be atherothrombotic lesions. Patients were classified into two groups: those with and without atherothrombotic lesions. Clinical outcomes, including all‐cause death, stroke, systemic embolization, and worsening renal function, were investigated.

Results

Of 278 patients, 116 (41.4%) exhibited atherothrombotic lesions. Baseline renal function was significantly worse in patients with atherothrombotic lesions. There were no significant differences in the occurrence of all‐cause death (0% vs. 0.6%; p > 0.99), stroke (3.5% vs. 2.5%; p = 0.72), systemic embolism (0.9% vs. 0%; p = 0.42), and worsening renal function (increase in serum creatinine ≥ 0.3 mg/dL or ≥ 1.5‐fold from baseline; 5.4% vs. 5.2%; p = 0.93) within 1‐month. During a median follow‐up of 3.0 years (interquartile range 2.0–4.0 years), the occurrence of all‐cause death was numerically higher in patients with atherothrombotic lesions compared to those without.

Conclusions

Atherothrombotic lesions were commonly observed in patients undergoing transfemoral TAVR. No significant clinical effect of aortic atherosclerosis on short‐term adverse outcomes was observed, although long‐term mortality was numerically higher in patients who exhibited atherothrombotic lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementFemoral ArteryAortic DiseasesAtherosclerosisAortic Valve StenosisCatheterization, PeripheralAortic ValveHumansMaleFemaleTreatment OutcomeAged, 80 and overRisk FactorsAgedTime FactorsRisk AssessmentSeverity of Illness IndexRetrospective StudiesAortographyComputed Tomography AngiographyPuncturesPlaque, AtheroscleroticEmbolism

Stichwörter der Autor:innen

TAVITAVRadverse outcomesaortic atherosclerosisaortic atherothrombotic lesions

Autor:innen und Institutionen

  • Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

ORCID-Profile: Akihito Tanaka, Tomonari Uemura

Zitieren

APA

Shirai, Y., Tanaka, A., Tokuda, Y., Kondo, H., Mizutani, K., Uemura, T., Furusawa, K., Mutsuga, M., & Murohara, T. (2025). Impact of Aortic Atherosclerosis on Clinical Outcomes After Transfemoral Transcatheter Aortic Valve Replacement. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70125

Vancouver

Shirai Y, Tanaka A, Tokuda Y, Kondo H, Mizutani K, Uemura T, et al. Impact of Aortic Atherosclerosis on Clinical Outcomes After Transfemoral Transcatheter Aortic Valve Replacement. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70125

BibTeX
@article{Shirai2025,
  author = {Shirai, Yoshinori and Tanaka, Akihito and Tokuda, Yoshiyuki and Kondo, Hiroki and Mizutani, Koji and Uemura, Tomonari and Furusawa, Kenji and Mutsuga, Masato and Murohara, Toyoaki},
  title = {Impact of Aortic Atherosclerosis on Clinical Outcomes After Transfemoral Transcatheter Aortic Valve Replacement},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70125}
}
Kostenlos starten →